Table 5.
Medications self-administered to treat suspected COVID-19.
| Pharmacological Class | Individual Medicine | Overall N (%) |
|---|---|---|
| Antibiotics | Amoxicillin (J01CA04) | 215 (27.8) |
| Co-amoxiclav (J01CR02) | 141 (18.2) | |
| Azithromycin (J01FA10) | 272 (35.1) | |
| Ciprofloxacin (J01MA02) | 106 (13.7) | |
| Levofloxacin (J01MA12) | 78 (10.1) | |
| Moxifloxacin (J01MA14) | 41 (5.3) | |
| Cefixime (J01DD08) | 88 (11.4) | |
| Erythromycin (J01FA01) | 84 (10.9) | |
| Doxycycline (J01AA02) | 81 (10.5) | |
| Antihistamines | Ebastine (R06AX22) | 49 (6.3) |
| Fexofenadine (R06AX26) | 56 (7.2) | |
| Cetirizine (R06AE07) | 85 (11.0) | |
| Anthelmintics | Ivermectin (P02CF01) | 70 (9.0) |
| Vitamins | Multivitamins | 254 (32.8) |
| Vitamin C + Calcium | 314 (40.6) | |
| Mineral supplements | Zinc supplement | 118 (15.2) |
| Antipyretics | Paracetamol | 774 (100.0) |
| Cough preparations | Cough preparations | 177 (22.8) |
| Herbal medicines | -- | 84 (10.9) |
| Others | -- | 51 (6.6) |
NB: N = 774.